Director/PDMR Shareholding

RNS Number : 6327H
Medica Group PLC
04 December 2020
 

Medica Group PLC

Director / PDMR Transaction and Shareholding

Medica Group PLC (LSE: MGP, "Medica" or the "Company"), has received notification from Mr Kevin Terrins, Director of Business Development, that on 3 December 2020 he transferred a total of 1,200,000 ordinary shares of 0.2p in the Company ("Shares") to his partner, Karen Freeburn, for nil consideration.

Following this transaction, there has been no change in the number of shares in which Kevin Terrins has an interest.

The Notification of Dealing Forms can be found below.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

 1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Kevin Terrins

2

 

Reason for the notification

 

a)

 

Position/status

 

Director of Business Development

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Medica Group PLC

b)

 

LEI

 

213800B8XE5FUSZF5Z16

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p

 

GB00BYV24996

 

 

b)

 

Nature of the transaction

 

Transfer of Ordinary Shares to Karen Freeburn

c)

Price(s) and volume(s)

 

 

Price (s)

Volumes (s)

N/A

1,200,000

d)

 

Aggregated information

-  Aggrated volume

-  Price

 

 

1,200,000

N/A

 

e)

 

Date of the transaction

 

3 December 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKQBPDBDDABK

Companies

Medica Group (MGP)
UK 100

Latest directors dealings